Physician profile
John D Bailey
NPI 1427063791
$856.92
in general payments reported to CMS, 2019-2025
20 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $66.16 · 2021: $88.85 · 2022: $154 · 2023: $41.82 · 2024: $174 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.34 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $163.03 | 2022-2023 | Keytruda, Lynparza |
| Intuitive Surgical, INC. | $133.99 | 2019-2020 | |
| Boston Scientific Corporation | $101.60 | 2024 | Axios, Spyglass |
| Astrazeneca Pharmaceuticals Lp | $68.49 | 2025 | Imfinzi |
| Davol INC. | $65.43 | 2022-2024 | Phasix Mesh |
| Novartis Pharmaceuticals Corporation | $36.30 | 2021 | |
| Innovation Technologies INC | $34.45 | 2025 | Irrisept |
| Ethicon US, LLC | $33.76 | 2019 | |
| Merit Medical Systems INC | $26.11 | 2021 | |
| Ambu INC. | $24.26 | 2025 | |
| Zimmer Biomet Holdings, INC. | $23.16 | 2019 | |
| Bard Peripheral Vascular, INC. | $20.51 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $19.05 | 2024 | |
| Csl Behring | $17.77 | 2020 | |
| Integra Lifesciences Corporation | $17.00 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $16.57 | 2025 | Miro3d |
| Aroa Biosurgery Incorporated | $16.42 | 2019 | |
| Myriad Genetic Laboratories, INC. | $14.20 | 2021 | |
| Mallinckrodt Enterprises LLC | $12.58 | 2019 | |
| Mallinckrodt Hospital Products INC. | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.